Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease: a Pilot Study

NCT04932434 is registered in ClinicalTrials.gov with Joshua Woolley, MD, PhD as lead sponsor.

NCT NCT04932434
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04932434 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease: a Pilot Study
Lead sponsor
Joshua Woolley, MD, PhD
Phase
Phase 2
Overall status
Completed
Start date
August 15, 2021
Completion date
December 31, 2024
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, depression, parkinson disease